Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Berry

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
JAMA Surgery|March 26, 2015
Sustainability and long-term effectiveness of the WHO surgical safety checklist combined with pulse oximetry in a resource-limited setting: two-year update from MoldovaRebecca Y Kim, Gifty Kwakye, Alvin C Kwok, et al.
Bulletin of the World Health Organization|March 12, 2016
Size and distribution of the global volume of surgery in 2012Thomas G Weiser, Alex B Haynes, George Molina, et al.
The New England Journal of Medicine|October 8, 2004
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerIan F Tannock, Ronald de Wit, William R Berry, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate CancerBridget F Koontz, Karen E Hoffman, Susan Halabi, et al.
Cancer Medicine|July 5, 2019
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancerMatthew D Tucker, Jason Zhu, Daniele Marin, et al.
The New England Journal of Medicine|January 18, 2013
Simulation-based trial of surgical-crisis checklistsAlexander F Arriaga, Angela M Bader, Judith M Wong, et al.
Annals of Surgery|November 16, 2017
Mortality Trends After a Voluntary Checklist-based Surgical Safety CollaborativeAlex B Haynes, Lizabeth Edmondson, Stuart R Lipsitz, et al.
Journal of the American College of Surgeons|August 15, 2015
Can 360-Degree Reviews Help Surgeons? Evaluation of Multisource Feedback for Surgeons in a Multi-Institutional Quality Improvement ProjectSuliat M Nurudeen, Gifty Kwakye, William R Berry, et al.
Prostate Cancer and Prostatic Diseases|February 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancerRyan E Fecteau, Bridget F Koontz, Karen E Hoffman, et al.
European Urology|May 11, 2016
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer CohortMatthew R Smith, Emmanuel S Antonarakis, Charles J Ryan, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
JAMA Surgery|March 26, 2015
Sustainability and long-term effectiveness of the WHO surgical safety checklist combined with pulse oximetry in a resource-limited setting: two-year update from MoldovaRebecca Y Kim, Gifty Kwakye, Alvin C Kwok, et al.
Bulletin of the World Health Organization|March 12, 2016
Size and distribution of the global volume of surgery in 2012Thomas G Weiser, Alex B Haynes, George Molina, et al.
The New England Journal of Medicine|October 8, 2004
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancerIan F Tannock, Ronald de Wit, William R Berry, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2020
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate CancerBridget F Koontz, Karen E Hoffman, Susan Halabi, et al.
Cancer Medicine|July 5, 2019
Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancerMatthew D Tucker, Jason Zhu, Daniele Marin, et al.
The New England Journal of Medicine|January 18, 2013
Simulation-based trial of surgical-crisis checklistsAlexander F Arriaga, Angela M Bader, Judith M Wong, et al.
Annals of Surgery|November 16, 2017
Mortality Trends After a Voluntary Checklist-based Surgical Safety CollaborativeAlex B Haynes, Lizabeth Edmondson, Stuart R Lipsitz, et al.
Journal of the American College of Surgeons|August 15, 2015
Can 360-Degree Reviews Help Surgeons? Evaluation of Multisource Feedback for Surgeons in a Multi-Institutional Quality Improvement ProjectSuliat M Nurudeen, Gifty Kwakye, William R Berry, et al.
Prostate Cancer and Prostatic Diseases|February 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancerRyan E Fecteau, Bridget F Koontz, Karen E Hoffman, et al.
European Urology|May 11, 2016
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer CohortMatthew R Smith, Emmanuel S Antonarakis, Charles J Ryan, et al.
Pageof 9